MN-25 is a synthetic cannabinoid (CB) with greater affinity for the peripheral CB2 receptor (Ki = 11 nM) than for the central CB1 receptor (Ki = 245 nM). However, this compound does not block LPS-induced TNF-α production in mice, an inhibitory effect produced by other CB2 agonists. This product is intended for forensic and research purposes.
